{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:18:57Z","timestamp":1787998737347,"version":"build-2784847793"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2006957"],"award-info":[{"award-number":["APP2006957"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2006957"],"award-info":[{"award-number":["APP2006957"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001230","name":"Macquarie University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001230","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Geriatr Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Psychotropic medicines are commonly used in residential aged care facilities (RACFs) despite notable safety concerns. No prior studies have examined the longitudinal concurrent use of psychotropic medicines. We aimed to identify trajectories of concurrent use of three psychotropic medication classes over time and determine predictors of trajectory group membership for residents with and without dementia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A retrospective longitudinal cohort study including 30 RACFs in Sydney, Australia. The study participants included 2837 newly admitted permanent residents (<jats:italic>n<\/jats:italic>\u2009=\u20091344 with dementia) aged\u2009\u2265\u200965 years. We monitored weekly exposure to three psychotropic classes\u2014antidepressants, antipsychotics, and anxiolytics\/hypnotics\u2014over three years. We used group-based multi-trajectory modelling to identify concurrent psychotropic medicine use.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>At baseline, 38.5%, 19.6%, and 16.7% of residents with dementia received antidepressants, antipsychotics, and anxiolytics\/hypnotics, respectively, compared to 32.8%, 7.1%, and 16.5% in residents without dementia. The concurrent use of multiple psychotropic classes occurred in 23.3% of non-dementia and 31.6% of dementia cohorts. The model identified 6-group and 4-group trajectories as the optimal fit for dementia and non-dementia cohorts, respectively. Psychotropic use trajectories mostly remained stable over time in non-dementia cohorts, while dementia cohorts showed more diverse and fluctuating use. Multinomial logistic regressions identified eleven predictors of trajectory membership in dementia and nine in non-dementia cohorts.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>One in three residents with dementia and one in five without dementia concurrently use multiple psychotropics often for extended periods, which may put residents at risk. Further research should assess the appropriateness of such use and consider strategies for improving health outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s41999-025-01171-6","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T16:34:41Z","timestamp":1740501281000},"page":"781-792","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identifying long-term patterns and predictors of concurrent psychotropic medicine use in residential aged care using group-based multi-trajectory modelling: the \u2018MEDTRAC-Psychotropics\u2019 longitudinal cohort study"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9740-6319","authenticated-orcid":false,"given":"Nasir","family":"Wabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Meulenbroeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desiree Chantelle","family":"Firempong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Urwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Timothy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena Z.","family":"Raban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Mumford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Westbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"1171_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.5694\/mja2.50501","volume":"212","author":"SL Harrison","year":"2020","unstructured":"Harrison SL, Sluggett JK, Lang C, Whitehead C, Crotty M, Corlis M, Wesselingh SL, Inacio MC (2020) The dispensing of psychotropic medicines to older people before and after they enter residential aged care. Med J Aust 212:309\u2013313","journal-title":"Med J Aust"},{"key":"1171_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1017\/S1041610218001229","volume":"31","author":"RE Brimelow","year":"2019","unstructured":"Brimelow RE, Wollin JA, Byrne GJ, Dissanayaka NN (2019) Prescribing of psychotropic drugs and indicators for use in residential aged care and residents with dementia. Int Psychogeriatr 31:837\u2013847","journal-title":"Int Psychogeriatr"},{"key":"1171_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2165\/00002018-200730020-00006","volume":"30","author":"B Takkouche","year":"2007","unstructured":"Takkouche B, Montes-Mart\u00ednez A, Gill SS, Etminan M (2007) Psychotropic medications and the risk of fracture: a meta-analysis. Drug Saf 30:171\u2013184","journal-title":"Drug Saf"},{"key":"1171_CR4","volume-title":"Professional practice guideline 10","author":"The Royal Australian and New Zealand College of Psychiatrists","year":"2016","unstructured":"The Royal Australian and New Zealand College of Psychiatrists (2016) Professional practice guideline 10. RANZCP, Melbourne"},{"key":"1171_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.18773\/austprescr.2019.011","volume":"42","author":"K Westaway","year":"2019","unstructured":"Westaway K, Blacker N, Shute R, Allin R, Elgebaly Z, Frank O, Pratt N, Roughead E (2019) Combination psychotropic medicine use in older adults and risk of hip fracture. Aust Prescr 42:93\u201396","journal-title":"Aust Prescr"},{"issue":"71","key":"1171_CR6","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","volume":"2023","author":"By the American Geriatrics Society Beers Criteria\u00ae Update Expert P: American Geriatrics Society","year":"2023","unstructured":"By the American Geriatrics Society Beers Criteria\u00ae Update Expert P: American Geriatrics Society (2023) updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2023(71):2052\u20132081","journal-title":"J Am Geriatr Soc"},{"key":"1171_CR7","unstructured":"Psychotropic drugs. In: Australian Medicines Handbook (AMH). Australian Medicines Handbook Pty Ltd; 2023. https:\/\/amhonline.amh.net.au\/chapters\/psychotropic-drugs?menu=vertical. Accessed 16 Aug 2024"},{"key":"1171_CR8","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1017\/S104161021600082X","volume":"28","author":"K van der Spek","year":"2016","unstructured":"van der Spek K, Gerritsen DL, Smalbrugge M, Nelissen-Vrancken MH, Wetzels RB, Smeets CH, Zuidema SU, Koopmans RT (2016) Only 10% of the psychotropic drug use for neuropsychiatric symptoms in patients with dementia is fully appropriate. The PROPER I-study. Int Psychogeriatr 28:1589\u20131595","journal-title":"Int Psychogeriatr"},{"key":"1171_CR9","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1017\/S1041610220004032","volume":"33","author":"DJ Jester","year":"2021","unstructured":"Jester DJ, Molinari V, Zgibor JC, Volicer L (2021) Prevalence of psychotropic polypharmacy in nursing home residents with dementia: a meta-analysis. Int Psychogeriatr 33:1083\u20131098","journal-title":"Int Psychogeriatr"},{"key":"1171_CR10","unstructured":"About the QI Program. https:\/\/www.health.gov.au\/our-work\/qi-program\/about"},{"key":"1171_CR11","doi-asserted-by":"publisher","first-page":"e1001885","DOI":"10.1371\/journal.pmed.1001885","volume":"12","author":"EI Benchimol","year":"2015","unstructured":"Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Peteresen I, S\u00f8rensen HT, von Elm E, Langan SM (2015) The reporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med 12:e1001885\u2013e1001885","journal-title":"PLoS Med"},{"key":"1171_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12963-020-00234-z","volume":"18","author":"KE Lind","year":"2020","unstructured":"Lind KE, Raban MZ, Brett L, Jorgensen ML, Georgiou A, Westbrook JI (2020) Measuring the prevalence of 60 health conditions in older Australians in residential aged care with electronic health records: a retrospective dynamic cohort study. Popul Health Metrics 18:25","journal-title":"Popul Health Metrics"},{"key":"1171_CR13","volume-title":"Psychotropic medications used in Australia\u2014information for aged care","author":"Aged Care Quality and Safety Commission","year":"2020","unstructured":"Aged Care Quality and Safety Commission (2020) Psychotropic medications used in Australia\u2014information for aged care. ACQSC, Sydney"},{"key":"1171_CR14","volume-title":"Behaviour management a guide to good practice","author":"K Burns","year":"2012","unstructured":"Burns K, Jaysinha R, Tsang R, Brodaty H (2012) Behaviour management a guide to good practice. Dementia Collaborative Research- Centre Assessment and Better Care (DCRC-ABC), Kensington"},{"key":"1171_CR15","volume-title":"Clinical practice guidelines and priniciples of care for people with dementia","author":"National Health and Medical Research Council","year":"2016","unstructured":"National Health and Medical Research Council (2016) Clinical practice guidelines and priniciples of care for people with dementia. NHMRC, Canberra"},{"key":"1171_CR16","volume-title":"Reducing the use of sedative medication in aged care facilities: implementation of the \u2018RedUSe\u2019 project into everyday practice","author":"J Westbury","year":"2017","unstructured":"Westbury J, Gee P, Ling TIB, Brown D, Franks K, Hoyle D, Peterson G (2017) Reducing the use of sedative medication in aged care facilities: implementation of the \u2018RedUSe\u2019 project into everyday practice. Wicking Dementia Research and Education Centre, Hobart"},{"key":"1171_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1037\/1082-989X.4.2.139","volume":"4","author":"DS Nagin","year":"1999","unstructured":"Nagin DS (1999) Analyzing developmental trajectories: a semiparametric, group-based approach. Psychol Methods 4:139\u2013157","journal-title":"Psychol Methods"},{"key":"1171_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","volume":"6","author":"DS Nagin","year":"2010","unstructured":"Nagin DS, Odgers CL (2010) Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol 6:109\u2013138","journal-title":"Annu Rev Clin Psychol"},{"key":"1171_CR19","doi-asserted-by":"publisher","first-page":"e0161381","DOI":"10.1371\/journal.pone.0161381","volume":"11","author":"J Librero","year":"2016","unstructured":"Librero J, Sanf\u00e9lix-Gimeno G, Peir\u00f3 S (2016) Medication adherence patterns after hospitalization for coronary heart disease. A population-based study using electronic records and group-based trajectory models. PLoS ONE 11:e0161381","journal-title":"PLoS ONE"},{"key":"1171_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/pds.4917","volume":"29","author":"RP Hickson","year":"2020","unstructured":"Hickson RP, Annis IE, Killeya-Jones LA, Fang G (2020) Opening the black box of the group-based trajectory modeling process to analyze medication adherence patterns: an example using real-world statin adherence data. Pharmacoepidemiol Drug Saf 29:357\u2013362","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1171_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s12888-021-03403-y","volume":"21","author":"A Zhang","year":"2021","unstructured":"Zhang A, Fang J, Wan Y, Su P, Tao F, Sun Y (2021) Joint trajectories of life style indicators and their links to psychopathological outcomes in the adolescence. BMC Psychiatry 21:407","journal-title":"BMC Psychiatry"},{"key":"1171_CR22","doi-asserted-by":"publisher","first-page":"100279","DOI":"10.1016\/j.lanepe.2021.100279","volume":"13","author":"NK Adjei","year":"2022","unstructured":"Adjei NK, Schluter DK, Straatmann VS, Melis G, Fleming KM, McGovern R, Howard LM, Kaner E, Wolfe I, Taylor-Robinson DC, ORACLE consortium (2022) Impact of poverty and family adversity on adolescent health: a multi-trajectory analysis using the UK Millennium Cohort Study. Lancet Reg Health Eur 13:100279","journal-title":"Lancet Reg Health Eur"},{"key":"1171_CR23","unstructured":"Position statement on antidepressants and depression. https:\/\/www.rcpsych.ac.uk\/docs\/default-source\/improving-care\/better-mh-policy\/position-statements\/ps04_19---antidepressants-and-depression.pdf?sfvrsn=ddea9473_5"},{"key":"1171_CR24","first-page":"225","volume":"162","author":"AM Holbrook","year":"2000","unstructured":"Holbrook AM, Crowther R, Lotter A, Cheng C, King D (2000) Meta-analysis of benzodiazepine use in the treatment of insomnia. Can Med Assoc J 162:225\u2013233","journal-title":"Can Med Assoc J"},{"key":"1171_CR25","unstructured":"Benzodiazepines. https:\/\/www.primaryhealthtas.com.au\/wp-content\/uploads\/2023\/03\/A-guide-to-deprescribing-benzodiazepines.pdf"},{"key":"1171_CR26","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1017\/S1041610217002447","volume":"30","author":"M McMaster","year":"2018","unstructured":"McMaster M, Fielding E, Lim D, Moyle W, Beattie E (2018) A cross-sectional examination of the prevalence of psychotropic medications for people living with dementia in Australian long-term care facilities: issues of concern. Int Psychogeriatr 30:1019\u20131026","journal-title":"Int Psychogeriatr"},{"key":"1171_CR27","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.3390\/jcm12103389","volume":"12","author":"WM Bezabhe","year":"2023","unstructured":"Bezabhe WM, Radford J, Salahudeen MS, Bindoff I, Ling T, Gee P, Wimmer BC, Peterson GM (2023) Ten-year trends in psychotropic prescribing and polypharmacy in Australian general practice patients with and without dementia. J Clin Med 12:3389","journal-title":"J Clin Med"},{"key":"1171_CR28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12911-019-0821-0","volume":"19","author":"J Schj\u00f8tt","year":"2019","unstructured":"Schj\u00f8tt J, A\u00dfmus J (2019) A retrospective comparison of inappropriate prescribing of psychotropics in three Norwegian nursing homes in 2000 and 2016 with prescribing quality indicators. BMC Med Inform Decis Mak 19:102","journal-title":"BMC Med Inform Decis Mak"},{"key":"1171_CR29","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/pds.4142","volume":"26","author":"KH Halvorsen","year":"2017","unstructured":"Halvorsen KH, Selbaek G, Ruths S (2017) Trends in potentially inappropriate medication prescribing to nursing home patients: comparison of three cross-sectional studies. Pharmacoepidemiol Drug Saf 26:192\u2013200","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1171_CR30","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/gerona\/gln043","volume":"64A","author":"JT Hanlon","year":"2009","unstructured":"Hanlon JT, Boudreau RM, Roumani YF, Newman AB, Ruby CM, Wright RM, Hilmer SN, Shorr RI, Bauer DC, Simonsick EM et al (2009) Number and dosage of central nervous system medications on recurrent falls in community elders: the health, aging and body composition study. J Gerontol Ser A 64A:492\u2013498","journal-title":"J Gerontol Ser A"},{"key":"1171_CR31","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/gps.5047","volume":"34","author":"FH Boehlen","year":"2019","unstructured":"Boehlen FH, Freigofas J, Herzog W, Meid AD, Saum KU, Schoettker B, Brenner H, Haefeli WE, Wild B (2019) Evidence for underuse and overuse of antidepressants in older adults: results of a large population-based study. Int J Geriatr Psychiatry 34:539\u2013547","journal-title":"Int J Geriatr Psychiatry"},{"key":"1171_CR32","doi-asserted-by":"publisher","first-page":"432","DOI":"10.5694\/mja2.50921","volume":"214","author":"JK Sluggett","year":"2021","unstructured":"Sluggett JK, Bell JS, Lang C, Corlis M, Whitehead C, Wesselingh SL, Inacio MC (2021) Residential medication management reviews in Australian residential aged care facilities. Med J Aust 214:432\u2013433","journal-title":"Med J Aust"},{"key":"1171_CR33","unstructured":"Residential aged care quality indicators\u2014October to December 2021. https:\/\/www.gen-agedcaredata.gov.au\/www_aihwgen\/media\/2021-22-Quality-Indicators\/RACS-QI-report-October-to-December-2021-previous-releases.pdf"}],"container-title":["European Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-025-01171-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41999-025-01171-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-025-01171-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T06:20:33Z","timestamp":1750141233000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41999-025-01171-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1171"],"URL":"https:\/\/doi.org\/10.1007\/s41999-025-01171-6","relation":{},"ISSN":["1878-7657"],"issn-type":[{"value":"1878-7657","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"6 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JW is supported by an NHMRC Elizabeth Blackburn Leadership Fellowship (1174021), MZR is supported by a NHMRC Early Career Fellowship (APP1143941), and IM is supported by an NHRMC Postgraduate Scholarship (APP2013953).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study received ethics approval from the Macquarie University Human Research Ethics Committee (ref: 520231126749629).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, informed consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable. The waiver of consent was approved by the Macquarie University Human Research Ethics Committee as this study utilised retrospective data collected as part of routine care.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}